MedDataX Logo

Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)

NCT ID: NCT03157934

Last Updated: 2023-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

12000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-26

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

FAST is an investigator-initiated multicenter study embedded in a German multistate acute stroke network. The main objectives of the FAST study are to improve outcomes and quality of care for stroke patients, to quantify the number of patients in need of thrombectomy within an integrated stroke network, to study the best way of delivering and performing thrombectomy and to investigate the best model of pre-hospital selection and referral for stroke patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Since 2015, mechanical thrombectomy in patients with large vessel occlusion has become an evidence based highly efficient treatment. In contrast to thrombolysis, thrombectomy can only be delivered by qualified interventionalists at comprehensive stroke centers. Thus, the implementation of thrombectomy into clinical practice remains a challenge. The investigators aim to establish a population based approach within a patient registry in a federal state overarching regional stroke network covering over 4 million inhabitants and integrating approximately 30 hospitals with different levels of expertise. The registry will include data from all acute ischemic stroke patients - approx. 12.000 patients p.a - within the network. The investigators plan to establish a central multi-interface platform integrating clinical data from the prehospital, intrahospital and rehabilitation phase including mandatory quality assurance, neurological and neuroradiological treatment and outcome data. The registry will allow addressing important questions, such as how many patients are candidates for thrombectomy, how many resources are needed to meet that demand and how treatment procedures and times can be improved. The overarching aim is to deliver high quality stroke care to every patient in the region.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke Vascular Diseases Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Primary CSC (Comprehensive Stroke center) admission

Patients with primary admission to endovascular-ready hospital (comprehensive stroke center)

not applicable (observational study)

Intervention Type OTHER

Observational study without study related intervention

Primary non-CSC (non-Comprehensive Stroke Center) SU (Stroke Unit) admission

Patients with primary admission to non-endovascular-ready hospital with (regional/local) stroke unit

not applicable (observational study)

Intervention Type OTHER

Observational study without study related intervention

Non-acute stroke hospital admission

Patients with primary admission to non-acute stroke-ready hospital

not applicable (observational study)

Intervention Type OTHER

Observational study without study related intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

not applicable (observational study)

Observational study without study related intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Patients with ischemic stroke who are admitted to one of the hospitals of the Stroke Consortium Rhein-Neckar (FAST)
* informed consent

Exclusion Criteria

* no informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dietmar Hopp Stiftung

OTHER

Sponsor Role collaborator

University Hospital Heidelberg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. Wolfgang Wick

Chairman of the Neurologic Clinic

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wolfgang Wick, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Heidelberg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Heidelberg University Hospital

Heidelberg, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Loraine Busetto, Dr.

Role: CONTACT

[email protected]
+49622156 ext. 34149

Maja Zenz, PhD

Role: CONTACT

[email protected]
+49622156 ext. 34391

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Loraine Busetto, Dr.

Role: primary

[email protected]
+49622156 ext. 34149

Related Links

Access external resources that provide additional context or updates about the study.

https://twitter.com/FAST_Heidelberg

FAST on Twitter

http://www.fast-schlaganfall.de

FAST Website with download Resources

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FAST

Identifier Type: -

Identifier Source: org_study_id